Previous studies dealing with HER2 heterogeneity in gastric cancer have mainly focused on the concordance of HER2 status between endoscopic biopsy and surgically resected specimens, or between primary tissues and metastatic tissues [7–9, 16–19]. The gene discussed is ERBB2; the disease is gastric cancer.